Table 3.
Results of pooled logistic regression analysis on the effect of favipiravir on the primary and secondary outcomes
| Person-days | Event | Weighted event rate (per 1000 person-day) | Hazard ratio | 95% CI | P value | |
|---|---|---|---|---|---|---|
| Oxygen requirement | ||||||
| Regimen 1 | 31,990 | 119 | 3.69 | 0.825 | 0.657–1.04 | 0.098 |
| Regimen 2 | 50,161 | 308 | 6.12 | 1 | Reference | |
| 30-day fatality risk | ||||||
| Regimen 1 | 32,726 | 14 | 0.411 | 0.869 | 0.519–1.46 | 0.594 |
| Regimen 2 | 53,209 | 41 | 0.759 | 1 | Reference | |
| IMV/ECMO | ||||||
| Regimen 1 | 32,713 | 23 | 0.682 | 1.02 | 0.649–1.60 | 0.929 |
| Regimen 2 | 53,145 | 55 | 1.02 | 1 | Reference | |
IMV/ECMO invasive mechanical ventilation/extracorporeal membrane oxygenation